SAMANTHA WERKHEISER: Open Payments
NPI 1437893278 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 47 payments from 18 companies in 2025. Trend: 2023 $1,951 · 2024 $873 · 2025 $1,453
Food & beverage: $1,453
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $329 |
| Sumitomo Pharma America, Inc. | 11 | $231 |
| Boston Scientific Corporation | 2 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Antares Pharma, Inc. | 4 | $85 |
| Janssen Biotech, Inc. | 2 | $73 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $59 |
| Ferring Pharmaceuticals Inc. | 3 | $59 |
| Merck Sharp & Dohme LLC | 2 | $58 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $56 |
Products named: INTERSTIM, Bulkamid, ORGOVYX, GEMTESA, Nubeqa, XYOSTED, ADSTILADRIN, JOURNAVX.
Industry payments across GA — which companies pay providers there.
